We believe Innovation begins with a collision, breakthroughs come from persistence, always with leading quality and strict quality as the mission, every gram of peptide is born. lt is the crystallization of our scientific wisdom. Since its launch in 2023, MTpeptides is always forging ahead and continues to innovate, at present, the company has achieved commercial mass production of GLP-1, peptide products such as Semaglutide, Tirzepatide and Retatrutide etc. And has passed ISO9001, IS014001 and ISO45001 system certification, at this stage, the company has an annual output of 1500 kilograms, supply capacity of GLP-1 peptide products. becoming a leading domestic supplier of peptide products.

At MTpeptides, we believe in technology empowers the future, while innovation pulses through our vein eternally, we will continuously serve global clients by leveraging cutting-edge R&D processes, adhering to strict quality standards, serve customers all over the world.